SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ACRT about to move to new highs -- Ignore unavailable to you. Want to Upgrade?


To: Keith A Walker who wrote (6947)2/4/1999 11:54:00 AM
From: Ryan Plovie (Hijacked)  Read Replies (1) | Respond to of 7054
 
Keith,

The only reason I don't Actrade, is because I got forced out of the market, because I was 90% on margin, with 4 stocks. When the market crashed, it blew me out. Actrade was one of my holdings. I'm licking my wounds, studying, saving, and getting ready for my comeback. I should be back in the market about June 1.

My theory on the short shares is we were at 2,300,000 short shares back 5 months ago and in that time they have brought it down to 1,100,000. The stock's highest point in that time is 16 3/4. They have already bought back 1.2 million. I don't see 1 million being a factor anymore. I used to hope, sometimes prey for that short squeeze that never came.

I think there was some "BIG TIME" PRO'S OR MANIPULATION GOING ON.

I follow about 50 stocks everyday. Actrade being one.

Feel free to e-mail. Plovie@prodigy.com



To: Keith A Walker who wrote (6947)2/9/1999 1:23:00 PM
From: Z man  Read Replies (1) | Respond to of 7054
 
Nasdaq rates ACRT ( upper 10%) outstanding in revenue and earnings growth...
The following is an E-mail I received from Mitch today....

Dear Investor,
We had requested of Nasdaq to provide us with research concerning how does
ACRT's 5-year sales growth rate and earnings growth rate compare to other
public companies (Nasdaq and Nasdaq/AMEX/NYSE combined. The following
information is from their reply.

Mr. Menik:

Responding to your question about comparing ACRT sales and EPS growth
rates vs. Nasdaq, Amex, and NYSE companies:

ARCT has a 5 year sales growth rate* of 57.7
* This is above 96% of Amex companies (specifically greater than 410 of
the universe of 427)
* This is above 91.7% of the Nasdaq companies (specifically greater
than 1,569 of the universe of 1,711)
* This is above 97.2% of the NYSE companies (specifically 1,655 of the
universe of 1,702)

ARCT has a 5 year EPS growth rate* of 62
* This is above 93.3% of Amex companies (specifically greater than 168
of the universe of 180 )
* This is above 96.7% of the Nasdaq companies (specifically greater
than 785 of the universe of 812)
* This is above 96.3% of the NYSE companies (specifically 1,159 of the
universe of 1,203)

*the growth rate calculates a growth rate for those companies that have
greater than zero value for the first and the last time period.
Non-available or negative data in the interim period is discarded,
however no more than one year in five years can be invalid or the
company will be excluded from the universe.
**the universe includes: common stock only, companies with sales data
available for the last 5 years, only those companies listed on Nasdaq,
Amex, or the NYSE.
***Data sources: Factset/Compustat, as of 2/99.

Very truly yours,
Actrade International, Ltd.
Mitchell G. Menik
Investor Relations Manager

Regards
Zman